SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMULOGIC

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Getman who wrote (53)10/14/1996 8:15:00 PM
From: Rudy Saucillo   of 305
 
IMUL is certainly under accumulation. It's up 40% (from 7- 1/4 to 10-1/8) over the past few weeks on increasing volume. As seen on the intra-day trading charts, a number of 10k and 25k blocks have traded in the past week alone with an average daily volume significantly higher than the 76.6k average daily volume for the third quarter. If you follow IMUL options, you will have noticed accumulation of the February and May calls (IMUL trades on the Feb./May/Aug./Nov. cycle so these represent the current "far term" options). Although there has been no recent news from the company regarding a new Allervax partnership, clearly there is much anticipation from investors who believe the risk vs. reward of an IMUL investment is in their favor. Cheers! Rudy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext